Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Managing Cardiovascular and Cancer Risk Associated with JAK Inhibitors.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Managing Cardiovascular and Cancer Risk Associated with JAK Inhibitors.
Managing Cardiovascular and Cancer Risk Associated with JAK Inhibitors. Drug Saf. 2023 11; 46(11):1049-1071.
View in:
PubMed
subject areas
Antirheumatic Agents
Arthritis, Psoriatic
Arthritis, Rheumatoid
Clinical Trials, Phase III as Topic
Humans
Inflammatory Bowel Diseases
Janus Kinase Inhibitors
Neoplasms
Randomized Controlled Trials as Topic
authors with profiles
Pankti Reid